Why Pulse Biosciences Stock Popped Today
Investor pulses were racing for Pulse Biosciences (NASDAQ: PLSE) on Wednesday, as it was one of the better-performing medical device stocks on the market. This came down to an initiation of coverage by an analyst, backed by a rather positive evaluation of the company's business. Pulse's stock closed the day nearly 10% higher. The initiating party was Freedom Capital Markets' Keith Hinton, who believes Pulse stock is a buy at a price target of $73 per share. Image source: Getty Images. Continue reading